As an early stage start-up company, Intelect Medical is focused on developing its DBS products and therapies.  Our focus is on proving the benefits of our DBS therapy applications and our unique technology in phased clinical trials.  We continue to make progress in both our clinical research and the development of our unique DBS products.

Our sizeable portfolio of DBS intellectual property offers us opportunities beyond our current horizon, as well as the option to license and spin-out businesses that do not fit with our core strategy.